Multiple infantile hepatic hemangiomas leading to consumptive hypothyroidism successfully treated with propranolol: A case report

Hepatic hemangioma is a commonly encountered benign vascular tumour of liver during infancy. Acquired hypothyroidism is one of the rare manifestation of this entity. We report a 4-month-old infant born to a diabetic mother who developed acquired hypothyroidism not responding to treatment due to multiple hepatic hemangiomas. The mechanism behind is increased type 3 deiodinase activity due to hemangiomas of liver, which catalyses conversion of T4 to rT3 and T3 to T2. Hemangiomas were successfully treated with propranolol which lead to its regression and ultimately resulted in euthyroidism. Hence, screening for hepatic hemangioma should be done in all cases of congenital hypothyroidism not responding to thyroxine treatment. We also propose early initiation of treatment of hemangiomas with propranolol as the first line therapy to prevent growth retardation and intellectual loss.

[1]  Asami Osada,et al.  Combination therapy of propranolol, levothyroxine, and liothyronine was effective in a case of severe consumptive hypothyroidism associated with infantile hepatic hemangioma , 2019, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

[2]  S. Hoey,et al.  Resolution of Consumptive Hypothyroidism Secondary to Infantile Hepatic Hemangiomatosis with a Combination of Propranolol and Levothyroxine , 2018, Journal of clinical research in pediatric endocrinology.

[3]  E. Şimşek,et al.  Severe consumptive hypothyroidism caused by multiple infantile hepatic haemangiomas , 2018, Journal of pediatric endocrinology & metabolism : JPEM.

[4]  S. Emir,et al.  The association of consumptive hypothyroidism secondary to hepatic hemangioma and severe heart failure in infancy. , 2016, Turk pediatri arsivi.

[5]  Sabyasachi Das,et al.  Symptomatic Infantile Hepatic Hemangioendothelioma Successfully Treated with Steroid , 2013, Journal of clinical neonatology.

[6]  R. Arnon,et al.  Propranolol as a first-line treatment for diffuse infantile hepatic hemangioendothelioma. , 2012, Journal of pediatric gastroenterology and nutrition.

[7]  S. Wajner,et al.  Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease. , 2011, The Journal of endocrinology.

[8]  Z. Aycan,et al.  Hypothyroidism Due to Hepatic Hemangioendothelioma: A Case Report , 2010, Journal of clinical research in pediatric endocrinology.

[9]  N. Howard,et al.  Case report: consumptive hypothyroidism consequent to multiple infantile hepatic haemangiomas , 2008, Current opinion in pediatrics.

[10]  J. Mulliken,et al.  Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. , 2007, Journal of pediatric surgery.

[11]  Ayla Güven,et al.  Severe Hypothyroidism Caused by Hepatic Hemangioendothelioma in an Infant of a Diabetic Mother , 2005, Hormone Research in Paediatrics.

[12]  J. Ho,et al.  New Insight into the Pathophysiology of Severe Hypothyroidism in an Infant with Multiple Hepatic Hemangiomas , 2005, Journal of pediatric endocrinology & metabolism : JPEM.

[13]  G. Hausdorf,et al.  Interventional treatment of infantile hepatic hemangioendothelioma. , 2003, Journal of pediatric surgery.